Kirsten M. Anderson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kirsten M. Anderson has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Brian M. Freed
Division of Allergy and Clinical Immunology, School of Medicine, University of Colorado Denver, 13001 E 17th Pl, Aurora, CO, 80045, USA
7 shared publications - Michael T. Aubrey
ClinImmune Labs, 12705 E. Montview Blvd, Suite 250, Aurora, CO 80045, USA
6 shared publications Brian Freed
University of Colorado Anschutz Medical Campus, Department of Medicine, Aurora, CO, United States of America
5 shared publications- Christina L. Roark
Univerisity of Colorado Cord Blood Bank & Clinimmune Lab, Aurora, Colorado
5 shared publications Christina Roark
ClinImmune Labs Aurora, CO, United States of America
5 shared publicationsMichael Aubrey
University of Colorado Anschutz Medical Campus, Department of Medicine, Aurora, CO, United States of America
5 shared publications
Latest Publications
- Open Access
- 24 July 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 205 (5) , 1323-1330
Killer Cell Immunoglobulin-like Receptor Variants Are Associated with Protection from Symptoms Associated with More Severe Course in Parkinson Disease
Immune dysfunction plays a role in the development of Parkinson disease (PD). NK cells regulate immune functions and are modulated by killer cell immunoglobulin-like receptors (KIR). KIR are expressed on the surface of NK cells and interact with HLA class I ligands on the surface of all nucleated cells. We investigated KIR-allelic polymorphism to interrogate the role of NK cells in PD. We sequenced KIR genes from 1314 PD patients and 1978 controls using next-generation methods and identified KIR genotypes using custom bioinformatics. We examined associations of KIR with PD susceptibility and disease features, including age at disease onset and clinical symptoms. We identified two KIR3DL1 alleles encoding highly expressed inhibitory receptors associated with protection from PD clinical features in the presence of their cognate ligand: KIR3DL1*015/HLA-Bw4 from rigidity (pc = 0.02, odds ratio [OR] = 0.39, 95% confidence interval [CI] 0.23–0.69) and KIR3DL1*002/HLA-Bw4i from gait difficulties (pc = 0.05, OR = 0.62, 95% CI 0.44–0.88), as well as composite symptoms associated with more severe disease. We also developed a KIR3DL1/HLA interaction strength metric and found that weak KIR3DL1/HLA interactions were associated with rigidity (pc = 0.05, OR = 9.73, 95% CI 2.13–172.5). Highly expressed KIR3DL1 variants protect against more debilitating symptoms of PD, strongly implying a role of NK cells in PD progression and manifestation.
- 24 July 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 205 (5) , 1323-1330
Open AccessKiller Cell Immunoglobulin-like Receptor Variants Are Associated with Protection from Symptoms Associated with More Severe Course in Parkinson Disease
Immune dysfunction plays a role in the development of Parkinson disease (PD). NK cells regulate immune functions and are modulated by killer cell immunoglobulin-like receptors (KIR). KIR are expressed on the surface of NK cells and interact with HLA class I ligands on the surface of all nucleated cells. We investigated KIR-allelic polymorphism to interrogate the role of NK cells in PD. We sequenced KIR genes from 1314 PD patients and 1978 controls using next-generation methods and identified KIR genotypes using custom bioinformatics. We examined associations of KIR with PD susceptibility and disease features, including age at disease onset and clinical symptoms. We identified two KIR3DL1 alleles encoding highly expressed inhibitory receptors associated with protection from PD clinical features in the presence of their cognate ligand: KIR3DL1*015/HLA-Bw4 from rigidity (pc = 0.02, odds ratio [OR] = 0.39, 95% confidence interval [CI] 0.23–0.69) and KIR3DL1*002/HLA-Bw4i from gait difficulties (pc = 0.05, OR = 0.62, 95% CI 0.44–0.88), as well as composite symptoms associated with more severe disease. We also developed a KIR3DL1/HLA interaction strength metric and found that weak KIR3DL1/HLA interactions were associated with rigidity (pc = 0.05, OR = 9.73, 95% CI 2.13–172.5). Highly expressed KIR3DL1 variants protect against more debilitating symptoms of PD, strongly implying a role of NK cells in PD progression and manifestation.
- Open Access
- 25 March 2019
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (15) , 7419-7424
A specific amino acid motif ofHLA-DRB1mediates risk and interacts with smoking history in Parkinson’s disease
Significance: Parkinson’s disease (PD) is a chronic, progressive neurodegenerative disease with both familial and sporadic forms and a clear genetic component. In addition, underlying immunoregulatory dysfunction and inflammatory processes have been implicated in PD pathogenesis. In this study, deep sequencing ofHLAgenes, which encode highly variable cell surface immune receptors, reveals specific variants conferring either risk or protection in PD. Because a history of cigarette smoking is known to be protective in PD, we analyzed the interaction of these genetic variants with smoking history in PD patients and healthy controls and found that the genetic effects are modified by history of cigarette smoking. These results provide a molecular model that explains the unique epidemiology of smoking in PD.
- 25 March 2019
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (15) , 7419-7424
Open AccessA specific amino acid motif ofHLA-DRB1mediates risk and interacts with smoking history in Parkinson’s disease
Significance: Parkinson’s disease (PD) is a chronic, progressive neurodegenerative disease with both familial and sporadic forms and a clear genetic component. In addition, underlying immunoregulatory dysfunction and inflammatory processes have been implicated in PD pathogenesis. In this study, deep sequencing ofHLAgenes, which encode highly variable cell surface immune receptors, reveals specific variants conferring either risk or protection in PD. Because a history of cigarette smoking is known to be protective in PD, we analyzed the interaction of these genetic variants with smoking history in PD patients and healthy controls and found that the genetic effects are modified by history of cigarette smoking. These results provide a molecular model that explains the unique epidemiology of smoking in PD.
- Open Access
- 7 March 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (3) , e0213179
Pulmonary alveolar proteinosis: An autoimmune disease lacking an HLA association
Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by the accumulation of pulmonary surfactant in alveolar macrophages and alveoli, resulting in respiratory impairment and an increased risk of opportunistic infections. Autoimmune PAP is an autoimmune lung disease that is caused by autoantibodies directed against granulocyte-macrophage colony-stimulating factor (GM-CSF). A shared feature among many autoimmune diseases is a distinct genetic association to HLA alleles. In the present study, we HLA-typed patients with autoimmune PAP to determine if this disease had any HLA association. We analyzed amino acid and allele associations for HLA-A, B, C, DRB1, DQB1, DPB1, DRB3, DRB4 and DRB5 in 41 autoimmune PAP patients compared to 1000 ethnic-matched controls and did not find any HLA association with autoimmune PAP. Collectively, these data may suggest the absence of a genetic association to the HLA in the development of autoimmune PAP.
- 7 March 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (3) , e0213179
Open AccessPulmonary alveolar proteinosis: An autoimmune disease lacking an HLA association
Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by the accumulation of pulmonary surfactant in alveolar macrophages and alveoli, resulting in respiratory impairment and an increased risk of opportunistic infections. Autoimmune PAP is an autoimmune lung disease that is caused by autoantibodies directed against granulocyte-macrophage colony-stimulating factor (GM-CSF). A shared feature among many autoimmune diseases is a distinct genetic association to HLA alleles. In the present study, we HLA-typed patients with autoimmune PAP to determine if this disease had any HLA association. We analyzed amino acid and allele associations for HLA-A, B, C, DRB1, DQB1, DPB1, DRB3, DRB4 and DRB5 in 41 autoimmune PAP patients compared to 1000 ethnic-matched controls and did not find any HLA association with autoimmune PAP. Collectively, these data may suggest the absence of a genetic association to the HLA in the development of autoimmune PAP.
- 1 September 2017
- Published by Elsevier in Human Immunology
- Vol. 78, 103
P067 Evaluation of HLA class II peptide binding prediction models against a robust experimental method
- 1 September 2017
- Published by Elsevier in Human Immunology
- Vol. 78, 103
P067 Evaluation of HLA class II peptide binding prediction models against a robust experimental method
- 1 September 2016
- Published by Elsevier in Human Immunology
- Vol. 77, 26
OR32 Potential role of loci in linkage disequilibrium with DRB1 in the pathogenesis of rheumatoid arthritis
- 1 September 2016
- Published by Elsevier in Human Immunology
- Vol. 77, 26
OR32 Potential role of loci in linkage disequilibrium with DRB1 in the pathogenesis of rheumatoid arthritis
- 1 September 2016
- Published by Elsevier in Human Immunology
- Vol. 77, 69
P0040 Binding of carbamylated peptides to alleles associated with susceptibility and resistance to rheumatoid arthritis
- 1 September 2016
- Published by Elsevier in Human Immunology
- Vol. 77, 69
P0040 Binding of carbamylated peptides to alleles associated with susceptibility and resistance to rheumatoid arthritis
- 1 August 2016
- Published by Elsevier in Journal of Autoimmunity
- Vol. 72, 25-32
Arthritogenic peptide binding to DRB1*01 alleles correlates with susceptibility to rheumatoid arthritis
- 1 August 2016
- Published by Elsevier in Journal of Autoimmunity
- Vol. 72, 25-32
Arthritogenic peptide binding to DRB1*01 alleles correlates with susceptibility to rheumatoid arthritis
- Open Access
- 11 February 2016
- Published by Wiley in Arthritis & Rheumatology
- Vol. 68 (7) , 1627-1636
A Molecular Analysis of the Shared Epitope Hypothesis: Binding of Arthritogenic Peptides to DRB1*04 Alleles
Objective: The shared epitope hypothesis posits that amino acids QR/KRAA in positions 70–74 of the DRΒ1 chain are responsible for rheumatoid arthritis susceptibility. However, even DRB1*04 alleles containing the shared epitope vary greatly with respect to degrees of susceptibility. This study was undertaken to conduct a molecular examination of the shared epitope hypothesis by measuring binding of arthritogenic peptides to susceptibility and resistance alleles.Methods: We measured binding of native and citrullinated forms of vimentin66–78 and α‐enolase11–25 and noncitrullinated type II collagen258–272 to 88 class II alleles on Luminex beads (which includes alleles of many varying degrees of susceptibility and resistance). We expressed DRΒ1*04:01, *04:02, and *08:01 in T2 cells and mutated DRΒ1*04:01 at positions 67, 70, 71, 74, and 86 to corresponding residues in DRB1*04:02, *04:03, *04:04, *04:05, and *08:01. Finally, we measured responses of 4 DRΒ1*04:01 restricted collagen258–272 T cell hybridomas against wild‐type DRΒ1*04:01, *04:02, and all mutated alleles.Results: The most susceptible allele, DRΒ1*04:01, preferentially bound citrullinated vimentin66–78 and citrullinated α‐enolase11–25 over the native forms. DRΒ1*04:02 exhibited no preference for citrullinated peptides, and *08:01 preferred native peptides. Similarly, DRB1*04:01 bound collagen258–272, but *04:02 and *08:01 did not. Mutating DRΒ1*04:01 at positions 70, 71, 74, and 86 to the corresponding residues in DRΒ1*04:02 or *08:01 dramatically reduced the specificity for citrullinated peptides and collagen258–272 binding.Conclusion: These observations demonstrate that while amino acids at positions 70, 71, and 74 within the shared epitope in DRΒ1 mediate binding and T cell responses of arthritogenic peptides, position 86 outside the shared epitope also plays a critical role.
- 11 February 2016
- Published by Wiley in Arthritis & Rheumatology
- Vol. 68 (7) , 1627-1636
Open AccessA Molecular Analysis of the Shared Epitope Hypothesis: Binding of Arthritogenic Peptides to DRB1*04 Alleles
Objective: The shared epitope hypothesis posits that amino acids QR/KRAA in positions 70–74 of the DRΒ1 chain are responsible for rheumatoid arthritis susceptibility. However, even DRB1*04 alleles containing the shared epitope vary greatly with respect to degrees of susceptibility. This study was undertaken to conduct a molecular examination of the shared epitope hypothesis by measuring binding of arthritogenic peptides to susceptibility and resistance alleles.Methods: We measured binding of native and citrullinated forms of vimentin66–78 and α‐enolase11–25 and noncitrullinated type II collagen258–272 to 88 class II alleles on Luminex beads (which includes alleles of many varying degrees of susceptibility and resistance). We expressed DRΒ1*04:01, *04:02, and *08:01 in T2 cells and mutated DRΒ1*04:01 at positions 67, 70, 71, 74, and 86 to corresponding residues in DRB1*04:02, *04:03, *04:04, *04:05, and *08:01. Finally, we measured responses of 4 DRΒ1*04:01 restricted collagen258–272 T cell hybridomas against wild‐type DRΒ1*04:01, *04:02, and all mutated alleles.Results: The most susceptible allele, DRΒ1*04:01, preferentially bound citrullinated vimentin66–78 and citrullinated α‐enolase11–25 over the native forms. DRΒ1*04:02 exhibited no preference for citrullinated peptides, and *08:01 preferred native peptides. Similarly, DRB1*04:01 bound collagen258–272, but *04:02 and *08:01 did not. Mutating DRΒ1*04:01 at positions 70, 71, 74, and 86 to the corresponding residues in DRΒ1*04:02 or *08:01 dramatically reduced the specificity for citrullinated peptides and collagen258–272 binding.Conclusion: These observations demonstrate that while amino acids at positions 70, 71, and 74 within the shared epitope in DRΒ1 mediate binding and T cell responses of arthritogenic peptides, position 86 outside the shared epitope also plays a critical role.
- 1 October 2015
- Published by Elsevier in Human Immunology
- Vol. 76, 22
OR11 Comparison of arthritogenic peptide binding to DRB1*01:01 and DRB1*01:02
- 1 October 2015
- Published by Elsevier in Human Immunology
- Vol. 76, 22
OR11 Comparison of arthritogenic peptide binding to DRB1*01:01 and DRB1*01:02
- 1 October 2015
- Published by Elsevier in Human Immunology
- Vol. 76, 35
OR43 Four DRβ1 amino acids mediate preferential binding of citrullinated peptides and collagen
- 1 October 2015
- Published by Elsevier in Human Immunology
- Vol. 76, 35
OR43 Four DRβ1 amino acids mediate preferential binding of citrullinated peptides and collagen